title: Comparisons of aprepitant and ondansetron.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Carides
authors.forename: Theodore
authors.initials: T
authors.lastname: Reiss
authors.forename: Christopher
authors.initials: C
authors.lastname: Lines
authors.forename: Bernadette
authors.initials: B
authors.lastname: McKeon
authors.forename: Pierre
authors.initials: P
authors.lastname: Diemunsch
mesh_terms: D000932:Antiemetics / Q000008:administration & dosage* / Q000627:therapeutic use; D000077608:Aprepitant; D018890:Chemoprevention / Q000592:standards; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage* / Q000627:therapeutic use; D017294:Ondansetron / Q000008:administration & dosage* / Q000627:therapeutic use; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000932:Antiemetics; D009025:Morpholines; D000077608:Aprepitant; D017294:Ondansetron